115 related articles for article (PubMed ID: 20358659)
1. Legal ephedra?
Consum Rep; 2010 Mar; 75(3):11. PubMed ID: 20358659
[No Abstract] [Full Text] [Related]
2. [Ephedrine and ephedra in weight loss products and other preparations].
van der Hooft CS; Stricker BH
Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
[TBL] [Abstract][Full Text] [Related]
3. Banning ephedra: good call, poor vision.
Gordon JS
Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
[No Abstract] [Full Text] [Related]
4. Medicine. Ephedra--scientific evidence versus money/politics.
Wolfe SM
Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
[No Abstract] [Full Text] [Related]
5. HHS to study ephedra, step up enforcement against illegal marketing.
FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
[No Abstract] [Full Text] [Related]
6. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
7. Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.
Shekelle P; Hardy ML; Morton SC; Maglione M; Suttorp M; Roth E; Jungvig L; Mojica WA; Gagné J; Rhodes S; McKinnon E
Evid Rep Technol Assess (Summ); 2003 Mar; (76):1-4. PubMed ID: 12647510
[No Abstract] [Full Text] [Related]
8. [Ephedra products from the Internet: dangerous herb].
Kaulen H
Dtsch Med Wochenschr; 2004 Feb; 129(9):420. PubMed ID: 15017985
[No Abstract] [Full Text] [Related]
9. Ephedra in perspective--a current review.
Abourashed EA; El-Alfy AT; Khan IA; Walker L
Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
[TBL] [Abstract][Full Text] [Related]
10. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
[TBL] [Abstract][Full Text] [Related]
11. Ephedra: once a boon, now a bane.
Scheindlin S
Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
[No Abstract] [Full Text] [Related]
12. American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra.
Hollister AS; Kearns GL
Clin Pharmacol Ther; 2003 Nov; 74(5):403-5. PubMed ID: 14586380
[No Abstract] [Full Text] [Related]
13. The need for regulation of dietary supplements--lessons from ephedra.
Fontanarosa PB; Rennie D; DeAngelis CD
JAMA; 2003 Mar; 289(12):1568-70. PubMed ID: 12672775
[No Abstract] [Full Text] [Related]
14. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
Reichertz PS
Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
[No Abstract] [Full Text] [Related]
15. Ephedra/ephedrine: cardiovascular and CNS effects.
Wooltorton E; Sibbald B
CMAJ; 2002 Mar; 166(5):633. PubMed ID: 11898947
[No Abstract] [Full Text] [Related]
16. JAMA patient page. Ephedra and ephedrine.
Torpy JM; Lynm C; Glass RM
JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
[No Abstract] [Full Text] [Related]
17. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
Seamon MJ; Clauson KA
J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
[TBL] [Abstract][Full Text] [Related]
18. Legal overview of likely FDA regulation of Internet promotion.
Scheineson MJ
Food Drug Law J; 1996; 51(4):697-716. PubMed ID: 11797736
[No Abstract] [Full Text] [Related]
19. A critical evaluation of Internet marketing of products that contain ephedra.
Ashar BH; Miller RG; Getz KJ; Pichard CP
Mayo Clin Proc; 2003 Aug; 78(8):944-6. PubMed ID: 12911041
[TBL] [Abstract][Full Text] [Related]
20. Concerning ephedra alkaloids for weight loss.
Inchiosa MA
Int J Obes (Lond); 2007 Sep; 31(9):1481; author reply 1482-3. PubMed ID: 17438560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
